Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
ClinicalTrials.gov study NCT02989844. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01272245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML
ClinicalTrials.gov study NCT03922100. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
ClinicalTrials.gov study NCT03591510. IPD Sharing: YES. Countries: 10. Publications: 0.
Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02101983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00939653. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating Mutations
ClinicalTrials.gov study NCT01522469. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
ClinicalTrials.gov study NCT01457885. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy
ClinicalTrials.gov study NCT00387647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML
ClinicalTrials.gov study NCT00820976. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy
ClinicalTrials.gov study NCT00878722. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
ClinicalTrials.gov study NCT02341495. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00880243. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01019317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission
ClinicalTrials.gov study NCT04914676. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients
ClinicalTrials.gov study NCT02614560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00129168. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML
ClinicalTrials.gov study NCT02626338. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN
ClinicalTrials.gov study NCT04639024. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)
ClinicalTrials.gov study NCT01475370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.